Search - tctmd.com

Displaying 101 - 120 of 130

Sort: Relevancy | Date

Presentation EuroPCR 2013

Two-year clinical outcomes in the EVOLVE FHU trial:A randomized evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stent

Presenter: 203171|Ian Meredith

May 31, 2013

Presentation EuroPCR 2013

One-Year Outcomes in 1010 Unselected Patients Treated with the PROMUS Element Everolimus-Eluting Stent: The Multicenter PROMUS Element European Post-Approval Surveillance Study

Presenter: 13956|Raul Moreno

May 31, 2013

Presentation EuroPCR 2013

Clinical, Angiographic and IVUS Outcomes of the NG PROMUS Clinical Trial Evaluating the Novel Promus PREMIER Stent

Presenter: 228635|John Ormiston

May 31, 2013

News Conference News EuroPCR 2013

EuroPCR 2013: From Cutting-Edge Devices to the Clinical Challenges

Caitlin E. Cox

May 29, 2013

Presentation EuroPCR 2013

PEPCAD China ISR

Presenter: Run-Lin Gao

May 23, 2013

News Conference News EuroPCR 2013

Paclitaxel-eluting Balloon Matches Taxus for Treating DES Restenosis

Jason Kahn

May 23, 2013

News Conference News EuroPCR 2013

COMFORTABLE-AMI: Biodegradable-Polymer DES Offers Lasting Benefit to STEMI Patients

Caitlin E. Cox

May 23, 2013

News Conference News EuroPCR 2013

Paclitaxel Delivery Key to PAD Intervention

Caitlin E. Cox

May 22, 2013

News Conference News EuroPCR 2013

Novel Stent Helps Treat Bifurcation Lesions in FIM Registry

Jason Kahn

May 22, 2013

Presentation EuroPCR 2013

First-in-man study of dedicated bifurcation sirolimus-eluting stent BiOSS LIM® – complete 6-month clinical results

Presenter: Robert J. Gil

May 22, 2013

Presentation EuroPCR 2013

First Report on the Pivotal DESolve Nx Trial: 6-month Clinical and Multimodality Imaging Results

Presenter: Alexandre Abizaid

May 21, 2013

News Conference News EuroPCR 2013

DESolve Nx: Bioresorbable DES Shows Positive Results at 6 Months

Jason Kahn

May 21, 2013

News Conference News EuroPCR 2012

EuroPCR 2012: Biodegradable Devices, Imaging Take Center Stage

Caitlin E. Cox

May 22, 2012

Presentation EuroPCR 2012

Twelve-month clinical and angiographic results of the multicenter first-in-man BIOSOLVE-I study with the Paclitaxel-Eluting Bioabsorbable Magnesium Scaffold

Presenter: 12690|Michael Haude

May 18, 2012

Presentation EuroPCR 2012

SORT OUT V Trial

Presenter: 153818|Evald Christiansen

May 18, 2012

News Conference News EuroPCR 2012

No Clear Winner in Tests Between Biodegradable-Polymer DES vs. Conventional SES

Caitlin E. Cox

May 18, 2012

Presentation EuroPCR 2012

Biolimus-Eluting Stents With Biodegradable Polymer Versus Bare Metal Stents in Acute Myocardial Infarction: the COMFORTABLE AMI Trial

Presenter: 168190|Lorenz Raber

May 18, 2012

Presentation EuroPCR 2012

APPOSITION III: Evaluation of the STENTYS self-apposing bare and drug-eluting stent in 1000 STEMI patients in a real-life setting: in-hospital and 30-day outcomes

Presenter: 166648|giovanni amoroso

May 18, 2012

Presentation EuroPCR 2012

A Randomized Comparison Between Everolimus- and Sirolimus-eluting Stent in Chronic Coronary Total Occlusions: Final Results of the CIBELES Trial

Presenter: 13956|Raul Moreno

May 18, 2012

News Conference News EuroPCR 2012

Trials Take on Permanent- vs. Biodegradable-Polymer Technology

Caitlin E. Cox

May 17, 2012

Advertisement

Two-year clinical outcomes in the EVOLVE FHU trial:A randomized evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stent

One-Year Outcomes in 1010 Unselected Patients Treated with the PROMUS Element Everolimus-Eluting Stent: The Multicenter PROMUS Element European Post-Approval Surveillance Study

Clinical, Angiographic and IVUS Outcomes of the NG PROMUS Clinical Trial Evaluating the Novel Promus PREMIER Stent

EuroPCR 2013: From Cutting-Edge Devices to the Clinical Challenges

PEPCAD China ISR

Paclitaxel-eluting Balloon Matches Taxus for Treating DES Restenosis

COMFORTABLE-AMI: Biodegradable-Polymer DES Offers Lasting Benefit to STEMI Patients

Paclitaxel Delivery Key to PAD Intervention

Novel Stent Helps Treat Bifurcation Lesions in FIM Registry

First-in-man study of dedicated bifurcation sirolimus-eluting stent BiOSS LIM® – complete 6-month clinical results

First Report on the Pivotal DESolve Nx Trial: 6-month Clinical and Multimodality Imaging Results

DESolve Nx: Bioresorbable DES Shows Positive Results at 6 Months

EuroPCR 2012: Biodegradable Devices, Imaging Take Center Stage

Twelve-month clinical and angiographic results of the multicenter first-in-man BIOSOLVE-I study with the Paclitaxel-Eluting Bioabsorbable Magnesium Scaffold

SORT OUT V Trial

No Clear Winner in Tests Between Biodegradable-Polymer DES vs. Conventional SES

Biolimus-Eluting Stents With Biodegradable Polymer Versus Bare Metal Stents in Acute Myocardial Infarction: the COMFORTABLE AMI Trial

APPOSITION III: Evaluation of the STENTYS self-apposing bare and drug-eluting stent in 1000 STEMI patients in a real-life setting: in-hospital and 30-day outcomes

A Randomized Comparison Between Everolimus- and Sirolimus-eluting Stent in Chronic Coronary Total Occlusions: Final Results of the CIBELES Trial

Trials Take on Permanent- vs. Biodegradable-Polymer Technology

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content